Home LiteratureArticle Details
PMID: 15107488 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene.

Nucleic acids research ·Vol. 32 ·No. 7 ·2004-00-00 ·Pages 2202-13

Kwun HJ, Jang KL

Abstract

Despite the extensive studies on the roles of hepatitis B virus X protein (HBx), the effects of HBx on the important cellular processes such as cell growth, cell transformation and apoptosis remain controversial. Our previous study showed that the balance between p53-dependent activation and p53-independent repression by HBx determines the expression level of cyclin-dependent kinase inhibitor p21. In the present study, we further demonstrate that HBx natural variants have differential effects on p21 expression. The critical sites in HBx were identified as residues Ser-101 for activation and Met-130 for repression, respectively. The HBx variants with Ser-101 instead of Pro-101 stabilized p53 more efficiently, probably by protecting it from the MDM2-mediated degradation. On the other hand, the Met-130-containing HBx strongly repressed p21 expression by inhibiting Sp1 activity. Overall, the effect of HBx on p21 expression seems to be determined by the balance between the opposite activities. Depending on their potentials to regulate p21 expression, HBx variants showed different effects on the cell cycle progression, and eventually on the cell growth rate, implicating its biological significance. The present study may provide a clue to explaining the contradictory results related to cell growth regulation by HBx as well as to understanding the progression of hepatic diseases in HBV-positive patients.

MeSH Terms
Amino Acid Motifs Amino Acid Sequence Carcinoma, Hepatocellular/genetics Cell Cycle Cell Division Cell Line, Tumor Cyclin-Dependent Kinase Inhibitor p21 Cyclins/genetics Gene Expression Regulation Hepatitis B/genetics Humans Molecular Sequence Data Mutation/genetics Promoter Regions, Genetic/genetics Trans-Activators/chemistry,genetics,metabolism Viral Regulatory and Accessory Proteins
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Cyclins Trans-Activators Viral Regulatory and Accessory Proteins hepatitis B virus X protein
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kwun Hyun Jin
Department of Microbiology, College of Natural Sciences, Pusan National University, Busan 609-735, Korea.
Jang Kyung Lib
References (50)
50 references, click to expand
  1. Control of cyclins, cyclin-dependent kinase inhibitors, p21 and p27, and cell cycle progression in rat hepatocytes by extracellular matrix.
    J Hepatol. 2000 Mar;32(3):488-96 PMID: 10735620
  2. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.
    Exp Cell Res. 1996 Nov 25;229(1):111-25 PMID: 8940255
  3. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis.
    Mutat Res. 2000 Jun 30;460(1):17-28 PMID: 10856831
  4. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Oncogene. 2000 Jul 13;19(30):3384-94 PMID: 10918595
  5. Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma.
    J Med Virol. 2000 Oct;62(2):177-84 PMID: 11002246
  6. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
    Oncogene. 2000 Oct 12;19(43):5010-9 PMID: 11042688
  7. Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway.
    J Virol. 2001 May;75(9):4247-57 PMID: 11287574
  8. Checkpoint genes in cancer.
    Ann Med. 2001 Mar;33(2):113-22 PMID: 11327114
  9. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis.
    Cytokine Growth Factor Rev. 2001 Jun-Sep;12(2-3):189-205 PMID: 11325602
  10. Aberrant cell cycle checkpoint function in transformed hepatocytes and WB-F344 hepatic epithelial stem-like cells.
    Carcinogenesis. 2001 Aug;22(8):1257-69 PMID: 11470757
  11. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
    Gene. 2001 Sep 5;275(1):163-8 PMID: 11574165
  12. Hepatitis B virus X protein: a multifunctional viral regulator.
    J Gastroenterol. 2001 Oct;36(10):651-60 PMID: 11686474
  13. Apoptosis and apoptosis related proteins in chronic viral liver disease.
    Apoptosis. 2002 Apr;7(2):133-41 PMID: 11865197
  14. Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53.
    J Gen Virol. 2002 Nov;83(Pt 11):2765-72 PMID: 12388812
  15. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.
    J Hepatol. 2003 Aug;39(2):253-61 PMID: 12873823
  16. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.
    Proc Natl Acad Sci U S A. 1982 Nov;79(22):6777-81 PMID: 6294651
  17. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level.
    Biochem Biophys Res Commun. 1991 May 15;176(3):985-92 PMID: 1645550
  18. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  19. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  20. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Genes Dev. 1993 Dec;7(12B):2575-86 PMID: 8276240
  21. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2230-4 PMID: 8134379
  22. Principles of CDK regulation.
    Nature. 1995 Mar 9;374(6518):131-4 PMID: 7877684
  23. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.
    Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11215-9 PMID: 7479968
  24. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter.
    J Biol Chem. 1995 Dec 1;270(48):28623-8 PMID: 7499379
  25. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.
    Cancer Res. 1995 Dec 15;55(24):6012-6 PMID: 8521383
  26. Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes.
    J Biol Chem. 1998 Dec 11;273(50):33327-32 PMID: 9837906
  27. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates.
    Arch Virol. 1998;143(12):2313-26 PMID: 9930189
  28. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers.
    Hepatology. 1999 Mar;29(3):946-53 PMID: 10051502
  29. Hepatitis B virus X protein inhibits nucleotide excision repair.
    Int J Cancer. 1999 Mar 15;80(6):875-9 PMID: 10074921
  30. Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis.
    J Cell Biochem. 1997 Mar 1;64(3):434-46 PMID: 9057101
  31. Mdm2 promotes the rapid degradation of p53.
    Nature. 1997 May 15;387(6630):296-9 PMID: 9153395
  32. Regulation of p53 stability by Mdm2.
    Nature. 1997 May 15;387(6630):299-303 PMID: 9153396
  33. The hepatitis B virus X gene induces p53-mediated programmed cell death.
    Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8162-7 PMID: 9223332
  34. Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor.
    J Neurosci. 1997 Aug 15;17(16):6122-32 PMID: 9236224
  35. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line.
    J Biol Chem. 1997 Aug 29;272(35):22199-206 PMID: 9268365
  36. Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner.
    Biochem Biophys Res Commun. 1997 Aug 18;237(2):457-60 PMID: 9268733
  37. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct.
    Cancer Res. 1997 Nov 15;57(22):5137-42 PMID: 9371515
  38. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.
    Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14707-12 PMID: 9405677
  39. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene.
    J Virol. 1998 Apr;72(4):3060-5 PMID: 9525629
  40. Functional interplay between p53 and E2F through co-activator p300.
    Oncogene. 1998 May 28;16(21):2695-710 PMID: 9652736
  41. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells.
    J Biol Chem. 1998 Aug 14;273(33):21137-44 PMID: 9694869
  42. Signaling to p53: breaking the MDM2-p53 circuit.
    Cell. 1998 Oct 2;95(1):5-8 PMID: 9778240
  43. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
    Oncogene. 1998 Nov 12;17(19):2437-44 PMID: 9824154
  44. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway.
    Cancer Res. 1996 Jan 1;56(1):31-5 PMID: 8548769
  45. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells.
    J Biol Chem. 1996 Jan 12;271(2):901-6 PMID: 8557703
  46. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
    Genes Dev. 1996 Jan 15;10(2):142-53 PMID: 8566748
  47. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis.
    Mol Cell Biol. 1996 Sep;16(9):4961-71 PMID: 8756655
  48. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases.
    J Virol. 1996 Aug;70(8):4978-85 PMID: 8764004
  49. Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma.
    Lancet. 1996 Aug 31;348(9027):625-6 PMID: 8774611
  50. Selective transcriptional regulations in the human liver cell by hepatitis B viral X protein.
    Biochem Biophys Res Commun. 2000 Jun 7;272(2):525-30 PMID: 10833446
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2004-00-00
Epub
2004-00-23
Pages
2202-13
Language
English
Region
England
NLM ID
0411011
PMCID
PMC407832
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com